Concepedia

Author

Katia Mazzocco

Istituto Giannina GasliniORCID

Also Known As

Angela di Vinci, K Mazzocco, K. MAZZOCCO, K. Mazzocco, Katia Mazzocco, Mazzocco Katia, Mazzocco, Katia

79

Publications

1.9K

Citations

26

H-Index

50

Concepts

All Affiliations

Istituto Giannina GasliniIstituti di Ricovero e Cura a Carattere ScientificoSt Anna Children's HospitalUniversity of PaduaInstitut Curie
KM

About

Katia Mazzocco is an author at Istituto Giannina Gaslini specializing in medicine, pathology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

17

598

2

Cell Biology

9

9

214

3

Biostatistics

2

2

43

4

Engineering

1

1

15

5

Cellular Physiology

1

1

24

Katia Mazzocco

×

40

Publications

1.8K

Citations

26

H-Index

YearCitations

Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients

Ida Casciano, Katia Mazzocco, Luca Boni,

Cell Death and Differentiation

2002

177

Quality Assessment of Genetic Markers Used for Therapy Stratification

I.M. Ambros, Jean Bénard, Maria Guida Boavida,

Journal of Clinical Oncology

2003

123

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

Gian Paolo Tonini, Luca Boni, Andrea Pession,

Journal of Clinical Oncology

1997

111

Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors

Maria Łastowska, C. Cullinane, S. Variend,

Journal of Clinical Oncology

2001

105

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

Gudrun Schleiermacher, Jean Michon, Agnès Ribeiro,

British Journal of Cancer

2011

98

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients

Pauline Depuydt, Valentina Boeva, Toby Dylan Hocking,

JNCI Journal of the National Cancer Institute

2018

92

Neuroblastoma in adolescents

Massimo Conte, Stefano Parodi, Bruno De Bernardi,

Cancer

2006

79

Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard,

Journal of Clinical Oncology

2021

73

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

Claudio Gambini, Massimo Conte, Gabriella Bernini,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2003

70

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study ‖

Martina Morini, Davide Cangelosi, Daniela Segalerba,

Cancers

2019

55

Page 1